Monoclonal antibodies and small molecules: on the cutting edge of Alzheimer’s disease therapy
Alzheimer’s disease (AD) remains a major global health challenge, with prevalence projected to increase dramatically in the coming decades and no effective treatments available. Current therapies offer only symptomatic relief, reinforcing the need for disease-modifying strategies targeting underlyin...
Spremljeno u:
| Glavni autori: | , , , , , , , , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Frontiers Media S.A.
2026-04-01
|
| Serija: | Frontiers in Cell and Developmental Biology |
| Teme: | |
| Online pristup: | https://www.frontiersin.org/articles/10.3389/fcell.2026.1766762/full |
| Oznake: |
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|